201 related articles for article (PubMed ID: 34091125)
1. The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.
Ennis GE; Kohli A; Jonaitis EM; Betthauser TJ; Oh JM; Taylor CE; Chin N; Koscik RL; Christian BT; Asthana S; Johnson SC; Bendlin BB
Neurobiol Aging; 2021 Sep; 105():174-185. PubMed ID: 34091125
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
[TBL] [Abstract][Full Text] [Related]
3. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
[TBL] [Abstract][Full Text] [Related]
4. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
5. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
7. Relationship of metabolic and endocrine parameters to brain glucose metabolism in older adults: do cognitively-normal older adults have a particular metabolic phenotype?
Nugent S; Castellano CA; Bocti C; Dionne I; Fulop T; Cunnane SC
Biogerontology; 2016 Feb; 17(1):241-55. PubMed ID: 26364049
[TBL] [Abstract][Full Text] [Related]
8. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
9. The association of regional cerebral blood flow and glucose metabolism in normative ageing and insulin resistance.
Deery HA; Liang E; Di Paolo R; Voigt K; Murray G; Siddiqui MN; Egan GF; Moran C; Jamadar SD
Sci Rep; 2024 Jun; 14(1):14574. PubMed ID: 38914735
[TBL] [Abstract][Full Text] [Related]
10. Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer's disease.
Im JJ; Jeong H; Bikson M; Woods AJ; Unal G; Oh JK; Na S; Park JS; Knotkova H; Song IU; Chung YA
Brain Stimul; 2019; 12(5):1222-1228. PubMed ID: 31196835
[TBL] [Abstract][Full Text] [Related]
11. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
[TBL] [Abstract][Full Text] [Related]
12. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
13. Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance.
Castellano CA; Baillargeon JP; Nugent S; Tremblay S; Fortier M; Imbeault H; Duval J; Cunnane SC
PLoS One; 2015; 10(12):e0144116. PubMed ID: 26650926
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
15. Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
Matthews DC; Mao X; Dowd K; Tsakanikas D; Jiang CS; Meuser C; Andrews RD; Lukic AS; Lee J; Hampilos N; Shafiian N; Sano M; David Mozley P; Fillit H; McEwen BS; Shungu DC; Pereira AC
Brain; 2021 Dec; 144(12):3742-3755. PubMed ID: 34145880
[TBL] [Abstract][Full Text] [Related]
16. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
17. Executive functions in patients with Alzheimer's disease, type 2 diabetes mellitus patients and cognitively healthy older adults.
Redondo MT; Beltrán-Brotóns JL; Reales JM; Ballesteros S
Exp Gerontol; 2016 Oct; 83():47-55. PubMed ID: 27451340
[TBL] [Abstract][Full Text] [Related]
18. Glucose hypometabolism is highly localized, but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults.
Nugent S; Castellano CA; Goffaux P; Whittingstall K; Lepage M; Paquet N; Bocti C; Fulop T; Cunnane SC
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1315-21. PubMed ID: 24735889
[TBL] [Abstract][Full Text] [Related]
19. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
20. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
Cutler NR
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):309-21. PubMed ID: 2948218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
